Form D · Pharmaceuticals
Aclipse Therapeutics LLC
Radnor, PA · CIK 0001730907
Offering snapshot reported Aug 24, 2020 · SEC filing
- Reported sold
- $115K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 5, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 24, 2020 | Initial | $115,000 | No comparison | 1 | SEC filing |
| Mar 23, 2020 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jun 19, 2019 | Initial | $200,000 | No comparison | 1 | SEC filing |
| Mar 22, 2019 | Amendment | $1,175,000 | $50,000vs Feb 15, 2019 | 4 | SEC filing |
| Mar 22, 2019 | Initial | $1,050,000 | No comparison | 3 | SEC filing |
| Feb 15, 2019 | Amendment | $1,125,000 | $50,000vs Oct 26, 2018 | 4 | SEC filing |
| Oct 26, 2018 | Amendment | $1,075,000 | $75,000vs Feb 15, 2018 | 3 | SEC filing |
| Feb 15, 2018 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373917
Source: Form D, filed Aug 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Raymond K Houck | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
170 North Radnor Chester Road Suite 350
Radnor, PA, 19087
Radnor, PA, 19087